People Directory : Dave Knaack

SHARE THIS:

Dave Knaack

Director, Technology Transfer

Office for Technology Transfer

Office Phone: +1 508 289 3556

dknaack@whoi.edu

» Lab/Group Site

WHOI Mailing Address:

Woods Hole Oceanographic Institution

266 Woods Hole Rd.

MS# 53

Woods Hole, MA 02543-1050

Research Statement

Issued US Patents

1

9,789,223

Polyurethanes for Osteoimplants

2

9,333,080

Injectable and moldable bone substitute materials

3

9,327,052

Polyurethanes for osteoimplants

4

9,107,751

Injectable and moldable bone substitute materials

5

8,771,719

Synthesis of a bone-polymer composite material

6

8,740,987

Tissue-derived mesh for orthopedic regeneration

7

8,686,064

Coupling agents for orthopedic biomaterials

8

8,545,864

Hemostatic bone graft

9

8,425,893

Polyurethanes for osteoimplants

10

8,333,985

Non-glycerol stabilized bone graft

11

8,002,843

Polyurethanes for osteoimplants

12

7,985,414

Polyurethanes for osteoimplants

13

7,959,941

Bone graft comprising a demineralized bone matrix and a stabilizing agent

14

7,270,813

Coupling agents for orthopedic biomaterials

15

7,163,691

Bone graft

16

6,599,516

Malleable implant containing solid element that resorbs or fractures to provide access channels

17

5,773,255

Glucose responsive insulin secreting .beta.-cell lines and method for producing same

18

5,712,159

Glucose responsive insulin secreting .beta.-cell lines and method for producing same

19

5,534,404

Glucose responsive insulin secreting .beta.-cell lines and method for producing same

Personal Statement

David Knaack, Ph.D. joined WHOI in 2013 as the Director for Technology Transfer with responsibilities for Commercializing New Technologies arising from WHOI’s relationship with the sea. In addition to marketing and licensing of new technologies, his role includes identifying, patenting and facilitating applied research for product advancement

Dr. Knaack joined WHOI after 24 years in the Medical Device/Biotech industry where he held leadership positions in Product Development and Research, most recently as Vice President of Product Development & Manufacturing at ORTHOCON/ABYRX, Inc.  His roles in four biomedical startups have given him a breadth of experience in product development, quality systems, regulatory, project management and the strategic development and commercialization of intellectual property.  His areas of technical expertise include: implantable medical devices, biomaterials and composites, biologically active molecules, polymer-tissue composites, and cell line development. He has expertise in a number of therapeutic areas including Diabetes, neurodegeneration, orthopedics, analgesia and hemostasis. Dr. Knaack has peer reviewed publications in the fields of biocomposites, biomaterials, tissue engineering and cell and molecular biology. He is is a registered patent agent, a named inventor on nineteen issued U.S. patents, and agent of record on two others. He holds a B.Sci. in Chemistry from St. Lawrence University and a Ph.D. in Neurochemistry from Cornell University. He completed post-doctoral work in Molecular Biology at Harvard Medical School as a Howard Hughes Fellow.

[back]